An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform

December 11, 2025 updated by: Mohanraj Thirumalai, University of Alabama at Birmingham

An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform: A Pilot Study

The purpose of this study to pilot test an accessible and inclusive artificial intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4CHRON) for health-related quality of life for adults with impaired mobility and chronic medical conditions.

Study Overview

Detailed Description

The AI4CHRON study will use a four-arm randomized control trial design. Eligible and consented participants will be assigned to one of four groups: 1) Scheduled coaching calls with gamified rewards, 2) Scheduled coaching calls with rewards independent of gamification, 3) No scheduled coaching calls with gamified rewards, and 4) No scheduled coaching calls with rewards independent of gamification. The active intervention period will be six months.

Study Type

Interventional

Enrollment (Actual)

212

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years or older
  • Diagnosis of heart disease, chronic lung disease, or Type 2 diabetes
  • Living with a permanent physical disability (i.e., spina bifida, multiple sclerosis, stroke,)
  • Have the ability to converse in and read English
  • Availability of a smartphone or computer

Exclusion Criteria:

  • Current enrollment in any structured intervention
  • Severe cognitive impairment
  • Severe untreated depression in the past 6 months
  • Major cardiac event in the past 12 months
  • Uncontrolled blood pressure
  • Resting tachycardia
  • Renal failure
  • Severe peripheral neuropathy
  • Active treatment for cancer in the past 12 months
  • Having both visual and hearing impairments (either of them is fine)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Scheduled Coaching Calls & Gamified Rewards
Participants will receive scheduled coaching calls and receive gamified rewards (i.e., earning points over time and converted to monetary gifts)
Experimental: No Scheduled Coaching Call & Gamified Rewards
Participants will not have scheduled coaching calls and receive gamified rewards (i.e., earning points over time and converted to monetary gifts)
Experimental: Scheduled Coaching Calls & Independent rewards (No Gamification)
Participants will receive scheduled coaching calls and receive fixed rewards (i.e., non-increasing)
Experimental: No Scheduled Coaching Calls & Independent Rewards (No Gamification)
Participants will not have scheduled coaching calls and receive fixed rewards (i.e., non-increasing)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health-related quality-of-life
Time Frame: 24 Weeks
Enabled version of Short-Form 36 (SF-36E)
24 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: 24 weeks
Godin leisure time exercise questionnaire
24 weeks
Usability
Time Frame: 24 weeks
System Usability Scale
24 weeks
Usability
Time Frame: 24 weeks
Health Information Technology Usability Evaluation Scale
24 weeks
Medication adherence
Time Frame: 24 weeks
Medication adherence rating scale
24 weeks
Medication adherence
Time Frame: 24 weeks
Turnkey Adherence Strategy Medication Adherence
24 weeks
Self-efficacy for managing depression
Time Frame: 24 weeks
PROMIS SF v1.0 Emotional Distress-Depression 4a
24 weeks
Self-efficacy for managing psychosocial illness
Time Frame: 24 weeks
PROMIS SF v1.0 Psychosocial illness impact 8a
24 weeks
Self-efficacy for managing emotions
Time Frame: 24 weeks
PROMIS SF v1.0 Managing Emotions 4a
24 weeks
Self-efficacy for managing medications
Time Frame: 24 weeks
PROMIS SF v1.0 Managing Emotions 4a
24 weeks
Self-efficacy for managing social interactions
Time Frame: 24 weeks
PROMIS SF v1.0 Social Interactions 4a
24 weeks
Physical Activity
Time Frame: 24 weeks
Measured via data from FitBit device (Minutes)
24 weeks
Physical Activity
Time Frame: 24 weeks
Measured via data from FitBit device (Steps)
24 weeks
Self-efficacy for managing symptoms
Time Frame: 24 weeks
PROMIS SF v1.0 Managing Symptoms 4a
24 weeks
Self-efficacy for managing daily activities
Time Frame: 24 weeks
PROMIS SF v1.0 Managing daily activities 4a
24 weeks
Self-efficacy for managing sleep disturbance
Time Frame: 24 weeks
PROMIS SF v1.0 Sleep Disturbance 4a
24 weeks
Self-efficacy for managing sleep-related impairments
Time Frame: 24 weeks
PROMIS SF v1.0 Sleep-related impairment
24 weeks
Dietary Intake
Time Frame: 24 weeks
Short Healthy Eating Index
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Actual)

October 31, 2025

Study Completion (Actual)

October 31, 2025

Study Registration Dates

First Submitted

July 27, 2022

First Submitted That Met QC Criteria

July 28, 2022

First Posted (Actual)

August 1, 2022

Study Record Updates

Last Update Posted (Actual)

December 18, 2025

Last Update Submitted That Met QC Criteria

December 11, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disability Physical

Clinical Trials on Scheduled Coaching + Gamified Rewards

Subscribe